Exchange: STO Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
4.00% SEK2.86
America/New_York / 17 mai 2024 @ 10:42
FUNDAMENTALS | |
---|---|
MarketCap: | 153.37 mill |
EPS: | -3.63 |
P/E: | -0.790 |
Earnings Date: | Jun 27, 2024 |
SharesOutstanding: | 53.63 mill |
Avg Daily Volume: | 0.0239 mill |
RATING 2024-05-17 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Sell | |
P/E: | Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.790 | sector: PE 19.76 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.03x |
Company: PE -0.790 | industry: PE 24.11 |
DISCOUNTED CASH FLOW VALUE |
---|
SEK-0.0160 (-100.56%) SEK-2.88 |
Date: 2024-05-18 |
Expected Trading Range (DAY) |
---|
SEK 2.30 - 3.42 ( +/- 19.55%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | SEK2.86 (4.00% ) |
Volume | 0.0730 mill |
Avg. Vol. | 0.0239 mill |
% of Avg. Vol | 305.13 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden. It offers nicotine chewing gum for smoking cessation and medical cannabis chewing gums for non-pharma applications, as well as for other applications, such as oromucosal drug delivery and allergic rhinitis. The company is based in Malmö, Sweden.